Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) [Phase 3]
Phase 3 trial comparing esomeprazole 20 mg or 40 mg with placebo to prevent peptic ulcers in subjects taking low-dose aspirin; results poste…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures [Phase 3]
Phase 3 clinical trial evaluating antibiotic prophylaxis to prevent surgical site infections after selected urgent abdominal procedures has …
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately [Phase 1]
Phase 1 trial comparing a single capsule containing esomeprazole and aspirin to taking the two drugs separately in peptic ulcer disease; the…
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients [Phase 4]
This Phase 4 trial assesses the safety and efficacy of Albis in preventing aspirin-induced gastrointestinal ulcers in patients taking low-do…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: China Survey of Peptic Ulcer Bleeding
A completed AstraZeneca-sponsored clinical trial in China evaluating peptic ulcer bleeding; the update notes completion but does not provide…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-07FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Oceanside Pharmaceuticals' omeprazole and sodium bicarbonate, updating labeling through a supple…
-
FDA approval · 2011-12-07FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to authorize the intravenous form of Protonix (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfiz…
-
FDA approval · 2011-12-06FDA Approved: METHSCOPOLAMINE BROMIDE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a generic methscopolamine bromide product in an Original Application for Breckenridge Pharmaceutical, Inc.
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment [Phase 4]
Phase 4 clinical trial update on the importance of cytokines in peptic ulcer disease; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers [Phase 3]
Phase 3 trial evaluating HZT-501 to reduce the risk of ibuprofen-associated peptic ulcers has completed with posted efficacy and safety resu…
-
FDA label_change · 2011-05-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth/Pfizer to update the product labeling.
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Pantoprazole sodium from Torrent Pharmaceuticals Limited under an original ANDA; a generic version of pantoprazole for conditio…
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original ANDA for pantoprazole sodium, a generic proton pump inhibitor manufactured by Mylan Pharmaceuticals. This approval…
-
FDA approval · 2011-01-06FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for famotidine submitted by Baxter Healthcare Corporation, resulting in a label change for the produ…
-
FDA approval · 2010-12-22FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for clarithromycin by Sandoz Inc., confirming the approval of a generic clarithromycin product under…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately [Phase 1]
Phase 1 trial comparing a single capsule combining esomeprazole and acetylsalicylic acid to taking the medications separately has completed.
-
FDA approval · 2010-11-23FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting approval for this generic proton pump inhibitor under an AN…
-
FDA approval · 2010-11-17FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for the generic omeprazole from Lannett Company, Inc., authorizing continued marketing under the…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers [Phase 4]
Phase 4 trial update on high-dose oral rabeprazole for preventing recurrent bleeding after endoscopic treatment of bleeding peptic ulcers; t…
-
FDA approval · 2010-09-03FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for Omeprazole and Sodium Bicarbonate.
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin [Phase 3]
Phase 3 trial comparing safety and treatment in osteoarthritis patients taking low-dose aspirin. The study has completed.
-
FDA label_change · 2010-07-16FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a labeling supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen. The update m…
-
FDA approval · 2010-07-15FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for famotidine.
-
CLINICAL_TRIALS research · 2010-06-08Clinical Trial Update: Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor [NA]
A clinical trial update about peptic ulcer disease in ischemic heart patients treated with aspirin and clopidogrel, with or without a proton…
-
FDA approval · 2010-05-27FDA Approved: FAMOTIDINE — Original Application (Navinta LLC)
FDA approves Navinta LLC's original application for famotidine. This approval permits a generic version of famotidine to enter the market.